Biotech Values

[DewDiligence]

Profile of ABT’s competition in the bioabsorbable stent market:

http://seekingalpha.com/article/1497092-abbott-labs-absorb-and-the-dissolvable-stent-race

ABT’s ABSORB product is approved for marketing in 30 countries, but is still in phase-3 in the US (#msg-83166556). As the above article notes, ABT prefers to call its ABSORB product a scaffold rather than a stent, as the latter term suggests permanence.